BioCentury
ARTICLE | Company News

Sirion, Tenby Pharma Inc. deal

September 25, 2006 7:00 AM UTC

Sirion reverse-merged with unlisted public shell company Tenby and raised $25 million through the sale of preferred stock to North Sound Capital. Sirion President and CEO Barry Butler will be presiden...